Elizabeth Hurlburt - 14 Jan 2023 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role: EVP, Head of Clinical Ops.
Signature: /s/ Elizabeth Masson-Hurlburt
Issuer symbol: CRMD
Transactions as of: 14 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 18 Jan 2023, 18:00:08 UTC
Previous filing: 23 Feb 2022
Next filing: 18 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CRMD	Common Stock						8,000	14 Jan 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRMD	Stock Option (Right to Buy Common Stock)	Award	$0	+125,000		$0.000000	125,000	14 Jan 2023	Common Stock	125,000	$4.43	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These options were granted on 1/14/2023. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.